<p>The U.S Food and Drug Administration said it is asking drugmakers for data on antimicrobials sold for use in each food animal, such as cows and chickens, as part of efforts to combat...
Since its inception in 2009, the FDA’s Safe Use Initiative has collaborated with these stakeholders to investigate new threats to patient safety and develop innovative programs to combat them.
The FDA has issued a warning based on 20 reported cases of ketoacidosis in patients using sodium-glucose co-transporter 2 inhibitors for type 2 diabetes.
The FDA has issued a warning based on 20 reported cases of ketoacidosis in patients using sodium-glucose co-transporter 2 inhibitors for type 2 diabetes.
The FDA has issued a warning based on 20 reported cases of ketoacidosis in patients using sodium-glucose co-transporter 2 inhibitors for type 2 diabetes.
